Molecular Analysis News Today

The latest news and information for the University of Kansas.

<p>Stanford researchers who previously pioneered a new kind of protein degradation have mapped out how the process works, which could lead to new drug therapies for diseases like Alzheimer’s and cancer, and for rare childhood enzyme disorders.</p>

Benjamin Miron, MD, explains the purpose of studying the molecular profile of intraductal carcinoma of the prostate, expands on the potential prognostic and targetable alterations identified in patients with this histology, and discusses the planned cohort expansion and analysis of RNA signatures in this population.

LOS ANGELES, June 1 (Xinhua) -- The U.S. National Cancer Institute (NCI) has launched a large precision medicine cancer initiative to test the effectiveness of treating adults and children with new drug combinations that target specific tumor alterations, the institute said on Thursday.

U.S. launches new initiative testing tumor drug combinations-

Miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

The combination of PARP and ATR inhibition with olaparib and ceralasertib was tolerable but showed limited efficacy in pediatric patients with advanced malignancies harboring DNA replication stress and DNA repair deficiencies, according to findings from arm N of the phase 1/2 AcSé-ESMART trial.

/PRNewswire/ -- Exai Bio today announced a collaboration agreement with Quantum Leap Healthcare Collaborative™ (QLHC) to broaden the use of Exais novel,...

Dublin, March 29, 2023 (GLOBE NEWSWIRE) -- The "Lipidomic Equipment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Offering, and...

Besides collecting and freely sharing cancer genome data, research organizations and consortia are integrating genomic and clinical information and offering analytical tools.